Agios Pharmaceuticals, Inc. (AGIO)
28.18
+0.18
(+0.62%)
USD |
NASDAQ |
May 01, 16:00
28.18
0.00 (0.00%)
After-Hours: 17:53
Agios Pharmaceuticals Profit Margin (Quarterly) : -477.7% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly & Co. | 37.36% |
| Biogen, Inc. | 13.29% |
| Catalyst Pharmaceuticals, Inc. | 34.53% |
| Apellis Pharmaceuticals, Inc. | -29.49% |
| Alnylam Pharmaceuticals, Inc. | 16.99% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -32.90% |
| Return on Assets | -30.65% |
| Return on Invested Capital | -31.80% |
| Gross Profit Margin (Quarterly) | 87.07% |
| Operating Margin (Quarterly) | -530.3% |
| Return on Net Operating Assets | -500.5% |